AB035. SOH24AB_121. Assessing factors associated with further nodal positivity in initially node positive breast cancer patients found to have a positive sentinel node after neoadjuvant chemotherapy

This is the authors' abstract. We don't add key points for this paper.

Background: Axillary lymph node dissection (ALND) remains the standard of care for patients who were initially node positive and are found to have a positive sentinel lymph node biopsy (SLNB) following neoadjuvant chemotherapy (NACT). Factors predictive of further nodal metastases in this group remain unclear. This study aimed to assess factors predictive of additional nodal positivity in patients with a positive SLNB after NACT.